Filing Details
- Accession Number:
- 0001193805-20-000880
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-22 16:06:29
- Reporting Period:
- 2020-07-20
- Accepted Time:
- 2020-07-22 16:06:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1280776 | Immunic Inc. | IMUX | Pharmaceutical Preparations (2834) | 562358443 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1773674 | Manfred Groeppel | 1200 Avenue Of The Americas, Suite 200 New York NY 10036 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-07-20 | 5,000 | $14.44 | 279,480 | No | 4 | S | Indirect | See footnote |
| Common Stock | Disposition | 2020-07-21 | 650 | $15.62 | 278,830 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
| No | 4 | S | Indirect | See footnote |
Footnotes
- These shares were sold pursuant to the Reporting Person's written trading plan pursuant to Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan"). The Plan was adopted in connection with certain tax liabilities related to the issuance of shares in the April 2019 exchange transaction between the Issuer (then known as Vital Therapies, Inc.) and Immunic AG.
- The Reporting Person is Director of Groeppel Investments UG (haftungsbeschrankt), which is the record holder of 278,830 shares of common stock of the Issuer, and exercises voting and dispositive power over such shares.
Billionaire Hedge Funds
